Compare FBIO & MMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBIO | MMLP |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | 78 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.0M | 90.8M |
| IPO Year | N/A | 2002 |
| Metric | FBIO | MMLP |
|---|---|---|
| Price | $2.75 | $2.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $17.00 | $3.00 |
| AVG Volume (30 Days) | ★ 494.2K | 46.0K |
| Earning Date | 05-15-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,653,009,000.00 |
| Revenue This Year | $55.22 | N/A |
| Revenue Next Year | $40.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $1.75 | $1.89 |
| 52 Week High | $4.53 | $3.54 |
| Indicator | FBIO | MMLP |
|---|---|---|
| Relative Strength Index (RSI) | 47.30 | 38.45 |
| Support Level | $2.53 | N/A |
| Resistance Level | $2.92 | $2.83 |
| Average True Range (ATR) | 0.19 | 0.23 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 8.46 | 25.23 |
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Martin Midstream Partners LP has a diverse set of operations focused on the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products, including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing, and distribution; and natural gas liquids marketing, distribution and transportation services. The company operates in four segment Terminalling and storage, Transportation, Sulfur service, and Specialty products segment. The majority of the revenue is derived from the Specialty products segment.